Rossmax International Ltd.
4121
Rank in Stocks
#24738
Rossmax International Ltd. is dedicated to creating and delivering a wide array... Rossmax International Ltd. is dedicated to creating and delivering a wide array of healthcare products and solutions. Their diverse product lineup includes advanced diagnostic and monitoring devices such as body composition scales, which provide readings for body fat, BMI, lean mass, muscle mass, water ratio, and overall body weight. They also offer various blood pressure monitors, including traditional sphygmomanometers, stethoscopes for internal sound auscultation, portable pulse oximeters for tracking blood oxygen saturation, non-contact infrared thermometers, and blood glucose monitoring systems for diabetes management. The company further extends its offerings to therapeutic and assistive medical equipment. This includes nebulizers for mist-based medication delivery, suction units for removing bodily fluids, aero spacers to enhance aerosolized drug administration, peak flow meters for respiratory function assessment, therapeutic heating pads, and anti-decubitus mattresses. Complementing its hardware, Rossmax provides the Healthstyle app, a unified digital platform enabling users to conveniently track key health metrics like blood pressure, blood glucose, SpO2, weight, and temperature. Rossmax's solutions cater to a broad spectrum of medical fields, including cardiovascular health, diabetes, respiratory conditions, fever management, and wound care. They also offer a specialized range of thermometers, scales, and nebulizers specifically designed for pediatric use. Founded in 1988 and headquartered in Taipei, Taiwan, Rossmax International Ltd. operates with a strong global footprint. The company exports its products and maintains active operations in numerous international markets, spanning Taiwan, Italy, Brazil, Mainland China, Germany, Ukraine, Poland, Iraq, India, the United Kingdom, Japan, and Turkey.
Share Price
$0.3719104
Last synced: 2026-11-10
Market Cap
$30.91M
Change (1 day)
0.83%
Change (1 year)
-26.11%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Rossmax International Ltd. (4121)
Category
Healthcare
EPS for Rossmax International Ltd. (4121)
EPS as of September 2026 TTM: $-0.02
According to Rossmax International Ltd.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.01, equal to its 2024 EPS of $-0.01.
EPS history for Rossmax International Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | 51.00% |
| 2025 | $-0.01 | 10.58% |
| 2024 | $-0.01 | 300.00% |
| 2023 | 0.00 | -103.96% |
| 2022 | $0.07 | 34.70% |
| 2021 | $0.05 | -25.65% |
| 2020 | $0.07 | 459.83% |
| 2019 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | -258,709.27% |
US
|
|
| $17.99 | -119,239.07% |
US
|
|
| $7.77 | -51,556.95% |
US
|
|
| $17.99 | -119,239.07% |
US
|
|
| $0.04 | -388.08% |
AU
|
Questions about Rossmax International Ltd.'s earnings per share (EPS)
What is Rossmax International Ltd.'s earnings per share (EPS)?
Rossmax International Ltd.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Sep 2026.
What was Rossmax International Ltd.'s earnings per share (EPS) in 2025?
In 2025, Rossmax International Ltd.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2024.
How has Rossmax International Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Rossmax International Ltd.'s earnings per share (EPS) was highest in 2022 ($0.07) and lowest in 2025 ($-0.01).
How does Rossmax International Ltd.'s earnings per share (EPS) compare with similar companies?
Rossmax International Ltd.'s earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.